Dow Jones

38 798,99

-0,22%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Sonus Pharmaceuticals (MM) (SNUS)
Sonus Pharmaceuticals (MM) (SNUS) Actualités

SNUS

Sonus (SNUS)

Sonus Pharmaceuticals (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:SNUS

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
21/08/2008	15h42	PR Newswire (US)	Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on	NASDAQ:SNUS
07/08/2008	22h41	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Current report filing (8-K)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
05/08/2008	23h02	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Quarterly Report (10-Q)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
21/07/2008	12h01	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
17/07/2008	21h10	PR Newswire (US)	Sonus Pharmaceuticals Receives Favorable NASDAQ Decision	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
03/07/2008	22h21	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
30/05/2008	17h37	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
30/05/2008	12h30	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Amended Securities Registration (section 12(g)) (8-A12G/A)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
28/05/2008	13h35	PR Newswire (US)	Sonus Pharmaceuticals and OncoGenex Technologies to Merge	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
29/04/2008	22h36	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Amended Annual Report (10-K/A)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
20/03/2008	22h57	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
14/03/2008	22h02	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Annual Report (10-K)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
13/02/2008	15h43	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc - Statement of Ownership (SC 13G)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
24/09/2007	19h41	Edgar (US Regulatory)	Sonus Pharmaceuticals Inc (Other) (8-K)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
03/08/2007	17h00	Business Wire	Sonus Pharmaceuticals Highlights Corporate Progress and Reports Second Quarter Financial Results	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
19/07/2007	23h30	Business Wire	Sonus Pharmaceuticals to Release Second Quarter Financial Results and Hold Quarterly Conference Call on August 3	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
13/06/2007	14h30	Business Wire	Sonus Pharmaceuticals Awarded Patent for TOCOSOL(R) Camptothecin, the Company's Second Oncology Product Candidate	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
04/06/2007	22h30	Business Wire	Sonus Pharmaceuticals to Participate in Upcoming Investor Conferences	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
09/05/2007	22h15	Business Wire	Sonus Pharmaceuticals Highlights Progress and Reports First Quarter Financial Results	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
08/05/2007	01h39	Business Wire	Sonus Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
04/05/2007	01h04	Business Wire	Sonus Pharmaceuticals to Release First Quarter Financial Results and Hold Conference Call on May 9	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
19/03/2007	23h39	Business Wire	Sonus Pharmaceuticals to Present at WBBA Invest Northwest(TM)	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
14/03/2007	21h15	Business Wire	Sonus Pharmaceuticals Reviews Key Achievements in 2006 and Reports Fourth Quarter and Full Year Financial Results	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
08/03/2007	00h20	Business Wire	Sonus Pharmaceuticals to Release Fourth Quarter and Full Year 2006 Financial Results and Hold Year-end Conference Call on March	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
07/12/2006	23h30	Business Wire	Sonus Pharmaceuticals to Participate in RBC Capital Markets Healthcare Conference, December 13	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
21/11/2006	23h30	Business Wire	Sonus Pharmaceuticals to Present at Lazard Capital Markets Third Annual Life Sciences Conference, November 29	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
16/11/2006	14h30	Business Wire	Sonus Pharmaceuticals Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel in Metastatic	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
08/11/2006	22h07	Business Wire	Sonus Pharmaceuticals Updates Corporate Progress and Reports Third Quarter Financial Results	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
31/10/2006	22h30	Business Wire	Sonus Pharmaceuticals to Release Third Quarter Financial Results and Hold Quarterly Conference Call November 8	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)
28/09/2006	14h30	Business Wire	Sonus Pharmaceuticals Initiates Phase 1 Clinical Trial for Company's Second Anti-cancer Drug, TOCOSOL(R) Camptothecin	NASDAQ:SNUS	Sonus Pharmaceuticals (MM)